-
2
-
-
33644872236
-
Risk groups for clinical complications of norovirus infections: An outbreak investigation
-
Mattner F, Sohr D, Heim A, Gastmeier P, Vennema H, Koopmans M. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect 2006; 12:69-74.
-
(2006)
Clin Microbiol Infect
, vol.12
, pp. 69-74
-
-
Mattner, F.1
Sohr, D.2
Heim, A.3
Gastmeier, P.4
Vennema, H.5
Koopmans, M.6
-
3
-
-
84869093870
-
The potential economic value of a human norovirus vaccine for the United States
-
Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. The potential economic value of a human norovirus vaccine for the United States. Vaccine 2012; 30:7097-104.
-
(2012)
Vaccine
, vol.30
, pp. 7097-7104
-
-
Bartsch, S.M.1
Lopman, B.A.2
Hall, A.J.3
Parashar, U.D.4
Lee, B.Y.5
-
4
-
-
84884815041
-
Proposal for a unified norovirus nomenclature and genotyping
-
Kroneman A, Vega E, Vennema H, et al. Proposal for a unified norovirus nomenclature and genotyping. Arch Virol 2013; 158: 2059-68.
-
(2013)
Arch Virol
, vol.158
, pp. 2059-2068
-
-
Kroneman, A.1
Vega, E.2
Vennema, H.3
-
5
-
-
84891541960
-
Genotypic and epidemiologic trends of norovirus outbreaks in the United States 2009-2013
-
Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinje J. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009-2013. J Clin Microbiol 2013; 52:147-55.
-
(2013)
J Clin Microbiol
, vol.52
, pp. 147-155
-
-
Vega, E.1
Barclay, L.2
Gregoricus, N.3
Shirley, S.H.4
Lee, D.5
Vinje, J.6
-
6
-
-
46049105910
-
Norwalk virus: How infectious is it?
-
Teunis PF, Moe CL, Liu P, et al. Norwalk virus: how infectious is it? J Med Virol 2008; 80:1468-76.
-
(2008)
J Med Virol
, vol.80
, pp. 1468-1476
-
-
Teunis, P.F.1
Moe, C.L.2
Liu, P.3
-
7
-
-
84903190763
-
Determination of the human infectious dose-50% for Norwalk virus
-
Atmar RL, Opekun AR, Gilger MA, et al. Determination of the human infectious dose-50% for Norwalk virus. J Infect Dis 2013.
-
(2013)
J Infect Dis
-
-
Atmar, R.L.1
Opekun, A.R.2
Gilger, M.A.3
-
8
-
-
84883388614
-
A mouse model for human norovirus
-
Taube S, Kolawole AO, Hohne M, et al. A mouse model for human norovirus. MBio 2013; 4:4 e00450-13.
-
(2013)
MBio
, vol.4
, Issue.4
-
-
Taube, S.1
Kolawole, A.O.2
Hohne, M.3
-
9
-
-
0036889419
-
Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice
-
Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 2002; 76:12335-43.
-
(2002)
J Virol
, vol.76
, pp. 12335-12343
-
-
Harrington, P.R.1
Lindesmith, L.2
Yount, B.3
Moe, C.L.4
Baric, R.S.5
-
10
-
-
77957005956
-
Serological correlate of protection against norovirus-induced gastroenteritis
-
Reeck A, Kavanagh O, Estes MK, et al. Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis 2010; 202:1212-8.
-
(2010)
J Infect Dis
, vol.202
, pp. 1212-1218
-
-
Reeck, A.1
Kavanagh, O.2
Estes, M.K.3
-
11
-
-
36248961689
-
A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model
-
Souza M, Costantini V, Azevedo MS, Saif LJ. A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model. Vaccine 2007; 25:8448-59.
-
(2007)
Vaccine
, vol.25
, pp. 8448-8459
-
-
Souza, M.1
Costantini, V.2
Azevedo, M.S.3
Saif, L.J.4
-
12
-
-
78651063204
-
Chimpanzees as an animal model for human norovirus infection and vaccine development
-
Bok K, Parra GI, Mitra T, et al. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci USA 2011; 108:325-30.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 325-330
-
-
Bok, K.1
Parra, G.I.2
Mitra, T.3
-
13
-
-
33744505294
-
Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains
-
LoBue AD, Lindesmith L, Yount B, et al. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 2006; 24:5220-34.
-
(2006)
Vaccine
, vol.24
, pp. 5220-5234
-
-
Lobue, A.D.1
Lindesmith, L.2
Yount, B.3
-
14
-
-
39849097577
-
Mechanisms of GII.4 norovirus persistence in human populations
-
Lindesmith LC, Donaldson EF, LoBue AD, et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 2008; 5:e31.
-
(2008)
PLoS Med
, vol.5
-
-
Lindesmith, L.C.1
Donaldson, E.F.2
Lobue, A.D.3
-
15
-
-
84856943397
-
Monoclonal antibodybased antigenic mapping of norovirus GII.4-2002
-
Lindesmith LC, Debbink K, Swanstrom J, et al. Monoclonal antibodybased antigenic mapping of norovirus GII.4-2002. J Virol 2012; 86:873-83.
-
(2012)
J Virol
, vol.86
, pp. 873-883
-
-
Lindesmith, L.C.1
Debbink, K.2
Swanstrom, J.3
-
16
-
-
84856907832
-
Genetic mapping of a highly variable norovirus GII.4 blockade epitope: Potential role in escape from human herd immunity
-
Debbink K, Donaldson EF, Lindesmith LC, Baric RS. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J Virol 2012; 86:1214-26.
-
(2012)
J Virol
, vol.86
, pp. 1214-1226
-
-
Debbink, K.1
Donaldson, E.F.2
Lindesmith, L.C.3
Baric, R.S.4
-
17
-
-
70350380129
-
Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding
-
Allen DJ, Noad R, Samuel D, Gray JJ, Roy P, Iturriza-Gomara M. Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J 2009; 6:150.
-
(2009)
Virol J
, vol.6
, pp. 150
-
-
Allen, D.J.1
Noad, R.2
Samuel, D.3
Gray, J.J.4
Roy, P.5
Iturriza-Gomara, M.6
-
19
-
-
84874689661
-
Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes
-
Lindesmith LC, Costantini V, Swanstrom J, et al. Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J Virol 2013; 87:2803-13.
-
(2013)
J Virol
, vol.87
, pp. 2803-2813
-
-
Lindesmith, L.C.1
Costantini, V.2
Swanstrom, J.3
-
20
-
-
84888611899
-
Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity
-
Debbink K, Lindesmith LC, Donaldson EF, et al. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis 2013; 208:1877-87.
-
(2013)
J Infect Dis
, vol.208
, pp. 1877-1887
-
-
Debbink, K.1
Lindesmith, L.C.2
Donaldson, E.F.3
-
21
-
-
80052294511
-
Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period
-
Boon D, Mahar JE, Abente EJ, et al. Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J Virol 2011; 85:8656-66.
-
(2011)
J Virol
, vol.85
, pp. 8656-8666
-
-
Boon, D.1
Mahar, J.E.2
Abente, E.J.3
-
22
-
-
84891700334
-
Characterization of blockade antibody responses in GII.2. 1976 SMV infected subjects
-
Swanstrom J, Lindesmith LC, Donaldson EF, Yount B, Baric RS. Characterization of blockade antibody responses in GII.2.1976 SMV infected subjects. J Virol 2013; 88:829-37.
-
(2013)
J Virol
, vol.88
, pp. 829-837
-
-
Swanstrom, J.1
Lindesmith, L.C.2
Donaldson, E.F.3
Yount, B.4
Baric, R.S.5
-
24
-
-
55549118890
-
Deceptive imprinting and immune refocusing in vaccine design
-
Tobin GJ, Trujillo JD, Bushnell RV, et al. Deceptive imprinting and immune refocusing in vaccine design. Vaccine 2008; 26:6189-99.
-
(2008)
Vaccine
, vol.26
, pp. 6189-6199
-
-
Tobin, G.J.1
Trujillo, J.D.2
Bushnell, R.V.3
-
25
-
-
84860997673
-
Immunogenicity and specificity of norovirus consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations
-
Parra GI, Bok K, Taylor R, et al. Immunogenicity and specificity of norovirus consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations. Vaccine 2012; 30:3580-6.
-
(2012)
Vaccine
, vol.30
, pp. 3580-3586
-
-
Parra, G.I.1
Bok, K.2
Taylor, R.3
-
26
-
-
78650941306
-
Quadrivalent human papillomavirus (HPV) vaccine: A review of safety, efficacy, and pharmacoeconomics
-
Pomfret TC, Gagnon JM Jr., Gilchrist AT. Quadrivalent human papillomavirus (HPV) vaccine: A review of safety, efficacy, and pharmacoeconomics. J Clin Pharm Ther 2011; 36:1-9.
-
(2011)
J Clin Pharm Ther
, vol.36
, pp. 1-9
-
-
Pomfret, T.C.1
Gagnon Jr., J.M.2
Gilchrist, A.T.3
-
27
-
-
78649587261
-
Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibodysecreting cells that express homing receptors for mucosal and peripheral lymphoid tissues
-
El-Kamary SS, Pasetti MF, Mendelman PM, et al. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibodysecreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 2010; 202:1649-58.
-
(2010)
J Infect Dis
, vol.202
, pp. 1649-1658
-
-
El-Kamary, S.S.1
Pasetti, M.F.2
Mendelman, P.M.3
-
28
-
-
84862260185
-
Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers
-
Ramirez K,Wahid R, Richardson C, et al. Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers. Clin Immunol 2012; 144:98-108.
-
(2012)
Clin Immunol
, vol.144
, pp. 98-108
-
-
Ramirez, K.1
Wahid, R.2
Richardson, C.3
-
29
-
-
83155182848
-
Norovirus vaccine against experimental human Norwalk virus illness
-
Atmar RL, Bernstein DI, Harro CD, et al. Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 2011; 365: 2178-87.
-
(2011)
N Engl J Med
, vol.365
, pp. 2178-2187
-
-
Atmar, R.L.1
Bernstein, D.I.2
Harro, C.D.3
-
31
-
-
84880786047
-
Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice
-
Tamminen K, Lappalainen S, Huhti L, Vesikari T, Blazevic V. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. PLoS One 2013; 8:e70409.
-
(2013)
PLoS One
, vol.8
-
-
Tamminen, K.1
Lappalainen, S.2
Huhti, L.3
Vesikari, T.4
Blazevic, V.5
-
32
-
-
0013651896
-
Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes
-
Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 2000; 182:302-5.
-
(2000)
J Infect Dis
, vol.182
, pp. 302-305
-
-
Tacket, C.O.1
Mason, H.S.2
Losonsky, G.3
Estes, M.K.4
Levine, M.M.5
Arntzen, C.J.6
-
33
-
-
84876931013
-
Norovirus P particle efficiently elicits innate, humoral and cellular immunity
-
Fang H, TanM, Xia M,Wang L, Jiang X. Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One 2013; 8: e63269.
-
(2013)
PLoS One
, vol.8
-
-
Fang, H.1
Tan, M.2
Xia, M.3
Wang, L.4
Jiang, X.5
-
34
-
-
84875592440
-
Polyvalent complexes for vaccine development
-
Wang L, Huang P, Fang H, et al. Polyvalent complexes for vaccine development. Biomaterials 2013; 34:4480-92.
-
(2013)
Biomaterials
, vol.34
, pp. 4480-4492
-
-
Wang, L.1
Huang, P.2
Fang, H.3
-
35
-
-
83055188637
-
A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles
-
Tamminen K, Huhti L, Koho T, et al. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology 2012; 135:89-99.
-
(2012)
Immunology
, vol.135
, pp. 89-99
-
-
Tamminen, K.1
Huhti, L.2
Koho, T.3
-
36
-
-
84863675596
-
Immunogenetic mechanisms driving norovirus GII.4 antigenic variation
-
Lindesmith LC, Beltramello M, Donaldson EF, et al. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog 2012; 8:e1002705.
-
(2012)
PLoS Pathog
, vol.8
-
-
Lindesmith, L.C.1
Beltramello, M.2
Donaldson, E.F.3
-
37
-
-
70349912037
-
Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients
-
Koo HL, DuPont HL. Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients. Clin Infect Dis 2009; 49:1069-71.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 1069-1071
-
-
Koo, H.L.1
Dupont, H.L.2
-
38
-
-
84869997744
-
Norovirus gastroenteritis in immunocompromised patients
-
Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012; 367:2126-32.
-
(2012)
N Engl J Med
, vol.367
, pp. 2126-2132
-
-
Bok, K.1
Green, K.Y.2
-
39
-
-
67649393351
-
Vaccination in the elderly: An immunological perspective
-
Chen WH, Kozlovsky BF, Effros RB, Grubeck-Loebenstein B, Edelman RSztein MB. Vaccination in the elderly: an immunological perspective. Trends Immunol 2009; 30:351-9.
-
(2009)
Trends Immunol
, vol.30
, pp. 351-359
-
-
Chen, W.H.1
Kozlovsky, B.F.2
Effros, R.B.3
Grubeck-Loebenstein, B.4
Edelman, R.5
Sztein, M.B.6
-
40
-
-
0038447242
-
Vaccinations for adult solidorgan transplant recipients: Current recommendations and protocols
-
Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solidorgan transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003; 16:357-64.
-
(2003)
Clin Microbiol Rev
, vol.16
, pp. 357-364
-
-
Duchini, A.1
Goss, J.A.2
Karpen, S.3
Pockros, P.J.4
-
42
-
-
84866526544
-
Epidemiology of foodborne norovirus outbreaks United States 2001-2008
-
Hall AJ, Eisenbart VG, Etingue AL, Gould LH, Lopman BA, Parashar UD. Epidemiology of foodborne norovirus outbreaks, United States, 2001-2008. Emerg Infect Dis 2012; 18:1566-73.
-
(2012)
Emerg Infect Dis
, vol.18
, pp. 1566-1573
-
-
Hall, A.J.1
Eisenbart, V.G.2
Etingue, A.L.3
Gould, L.H.4
Lopman, B.A.5
Parashar, U.D.6
|